select trial semaglutide nejm Beyond obesity: Novo's re-defines cardiovascular risk management Frontiers | Cardiovascular Safety and

Lancet Oncol 19 (5): 603-615, 2018

In this article, well take you on a journey through the history of Semaglutide, a medication that has transformed from a diabetes treatment to a weight loss wonder

Personalized care ensures that treatment aligns with an individuals overall health profile and long-term goals

Another placebo-controlled trial in older adults at high risk of dementia found that supplementation with vitamin C (200 mg/day) and vitamin E (500 mg/day) for 12 weeks did not alter any of the measured cognitive functions despite nonsignificantly lowering levels of F 2 -isoprostanes biomarkers of lipid peroxidation in vivo (176)